Aerovate Therapeutics

0 followers


Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.

Industries

Employees

11-50

Links

Org chart

Tim Noyes

Collapse
Hunter Gillies
Chief Medical Officer
George Eldridge
Chief Financial Officer
Sue Fischer
SVP, Development Operations
Stephen Yu
SVP, Quality
Sanjeev Khindri
SVP, Clinical Development
Cheryl Lassen
SVP, Clinical Development
Sean Plunkett
Vice President, Manufacturing And Device Engineering
Kevin Kee
VP Of Pharmaceutical Development
Donna Dea
Head of Regulatory
Laetitia Baudet-Mpoutou
Director Of Diversity, Equity, Inclusion And Belonging